跳轉至內容
Merck
全部照片(1)

重要文件

G004432

HPLC Analysis of Statins in Rat Plasma on Ascentis® Express C18 after SPE using Supel-Select HLB

application for SPE, application for LC-MS

登入查看組織和合約定價


About This Item

技術

LC/MS: suitable
solid phase extraction (SPE): suitable

測試參數

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: rat plasma spiked with provastin and atorvastin at 5 and 100 ng/mL
SPE tube/cartridge: Supel-Select HLB SPE, 30 mg/1 mL (54181-U)
condition: 0.5 mL methanol:acetonitrile (1:1, v/v); 0.5 mL DI water
sample addition: 0.5 mL
washing: 0.5 mL 5% methanol
elution: 0.5 mL methanol:acetonitrile (1:1, v/v)
column: Ascentis Express C18, 5 cm x 2.1 mm, 2.7 μm particles (53822-U)
eluate post-treatment: evaporate to dryness with nitrogen at 37 °C, reconstitute in 0.5 mL DI water
mobile phase: 0.1% acetic acid diluted in 60% methanol
flow rate: 0.2 mL/min
column temp.: 35 °C
detector: ABI 3200 QT; ESI(+), MRM (423.3/321.3, 423.3/101.0, 557.3/397.2 and 557.3/453.4)
injection: 5 μL

適合性

application for LC-MS
application for SPE

應用

clinical

法律資訊

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Supel is a trademark of Sigma-Aldrich Co. LLC

從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務